3-nitropropionic acid has been researched along with Genetic Predisposition in 8 studies
3-nitropropionic acid: succinate dehydrogenase inactivator; biosynthesized by FABACEAE plants from ASPARAGINE
3-nitropropanoic acid : A C-nitro compound that is propanoic acid in which one of the methyl hydrogens has been replaced by a nitro group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (87.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jovicic, A | 1 |
Zaldivar Jolissaint, JF | 1 |
Moser, R | 1 |
Silva Santos, Mde F | 1 |
Luthi-Carter, R | 1 |
Blum, D | 1 |
Galas, MC | 1 |
Pintor, A | 1 |
Brouillet, E | 1 |
Ledent, C | 1 |
Muller, CE | 1 |
Bantubungi, K | 1 |
Galluzzo, M | 1 |
Gall, D | 1 |
Cuvelier, L | 1 |
Rolland, AS | 1 |
Popoli, P | 1 |
Schiffmann, SN | 1 |
Saulle, E | 1 |
Gubellini, P | 1 |
Picconi, B | 2 |
Centonze, D | 1 |
Tropepi, D | 1 |
Pisani, A | 2 |
Morari, M | 1 |
Marti, M | 1 |
Rossi, L | 1 |
Papa, M | 1 |
Bernardi, G | 2 |
Calabresi, P | 2 |
Klivenyi, P | 2 |
Starkov, AA | 1 |
Calingasan, NY | 1 |
Gardian, G | 1 |
Browne, SE | 1 |
Yang, L | 1 |
Bubber, P | 1 |
Gibson, GE | 1 |
Patel, MS | 1 |
Beal, MF | 2 |
von Arnim, CA | 1 |
Hellweg, R | 1 |
Büchner, M | 1 |
Huber, R | 1 |
Riepe, MW | 1 |
Passino, E | 1 |
Sgobio, C | 1 |
Bonsi, P | 1 |
Barone, I | 1 |
Ghiglieri, V | 1 |
Ammassari-Teule, M | 1 |
Huang, QY | 1 |
Yu, L | 1 |
Ferrante, RJ | 2 |
Chen, JF | 1 |
Andreassen, OA | 1 |
Dedeoglu, A | 1 |
Albers, DW | 1 |
Carlson, EJ | 1 |
Epstein, CJ | 1 |
8 other studies available for 3-nitropropionic acid and Genetic Predisposition
Article | Year |
---|---|
MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington's disease-related mechanisms.
Topics: 3' Untranslated Regions; Animals; Apoptosis; Blotting, Western; Brain; Cell Survival; Cells, Culture | 2013 |
A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists.
Topics: Adenosine; Animals; Body Weight; Cell Death; Corpus Striatum; Disease Models, Animal; Drug Administr | 2003 |
Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease.
Topics: Acetylcholine; Adenosine Triphosphate; Animals; Cell Respiration; Dose-Response Relationship, Drug; | 2004 |
Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Caudate Nucleus; Cell Count; Cerebral Cortex; | 2004 |
Regional selectivity of amyloid mRNA expression and neurotrophins on repetitive inhibition of oxidative phosphorylation.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Brain Chemistry; Brain-Derived Ne | 2005 |
Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons.
Topics: Acetylcholine; Animals; Behavior, Animal; Cholinergic Fibers; Convulsants; Disease Models, Animal; E | 2006 |
Mutant SOD1G93A in bone marrow-derived cells exacerbates 3-nitropropionic acid induced striatal damage in mice.
Topics: Amyotrophic Lateral Sclerosis; Animals; Bone Marrow Cells; Bone Marrow Transplantation; Corpus Stria | 2007 |
Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Carrier Prote | 2001 |